Skip to content

DR. DESAIVE PATRICK

Active Private limited companyfounded 2008active for 17 yearsNeerleest 8, 1020 BrusselsKBO/BCE: BE 0808.525.880

Lifetime

17 annual accounts with figures on one time axis
peak of €129,799 in 2021
€31,252▲ €62,762
lowest -€103,941 in 2023
€12,736▲ €62,312
peak of €405,071 in 2021
€182,692▲ 7.5%
€10,546▼ 25.8%
Board1 name since 2008
1 director
Documentsfilings and deeds
14-08-202614 days late
2025micro format
Gross margin from -€31,510 to €31,252Profit of €12,736, after a lossDebts from €14,210 to €10,546Cash from €67,823 to €100,198

Key points

from the 2025 annual accounts

Equity

€182,692 from €405,071 in 2021

Equity fell by 55% in 4 years.

Result

€12,736 €12,736
-€49,6002024€12,7002025

Back in profit in 2025, after a loss of €49,576 in 2024.

Turnover

≈ €98,000 estimated

The micro format states no turnover.

Liquidity

14.00 was 9.04 in 2024

Short-term debts fell from €13,671 to €10,546.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Nine of the last ten came late. The 2023 accounts came in latest, 51 days after the end of the period.

Position in the sector

94.5%

Higher solvency than 90% of companies in human health. Sector median 63.0% · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,721 companies had the same profile as DR. DESAIVE PATRICK has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,721 companies, not a prediction for DR. DESAIVE PATRICK. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0808525880
Change of role: , from manager to director General meeting of 14-12-2023 · Gazette deed
Incorporation published on 30-12-2008 · Gazette deed
First establishment Neerleest 8, Brussels
All 31 events

Comparable companies

same main activity, similar in size and age
Company
DR. DESAIVE PATRICK Brussels €193,239 €31,252 94.5% -
VADOUD DERMATECH Uccle €207,372 €27,524 -45.7% -
Dechamps Neuroped Andenne €207,453 €32,326 93.5% 0.1
DOKTER VAN DYCK CYRIEL Ravels €200,470 €31,231 99.5% -
DR. JAN F. J. HENDRICKX Brecht €183,919 €27,455 88.0% -
mediren Wavre €204,545 €26,470 65.4% -
FORPATH CONSULTANCY & RESEARCH Antwerp €221,383 €33,366 58.2% -

These companies have the same main activity as DR. DESAIVE PATRICK: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €184,000 and €221,000, founded between 2005 and 2009.

Official details

Source: KBO
Status
Active since 18-12-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.334.971.5281020 Brussels, since 18-12-2008
Financial year end
31 December
Peppol
Reachable since 31-12-2025
Company details

Annual accounts 2025

€193,239▲ 4.9%
Filing
Filed on 14-08-2026
Financials

Insights on DR. DESAIVE PATRICK

DR. DESAIVE PATRICK files the micro format. That format states no turnover. The gross margin fell from €80,662 in 2009 to €31,252 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. DESAIVE PATRICK

What is the company number of DR. DESAIVE PATRICK?
The company number of DR. DESAIVE PATRICK is 0808.525.880. The VAT number is the same number with BE in front: BE 0808.525.880.
Where is DR. DESAIVE PATRICK based?
The registered office is at Neerleest 8, 1020 Brussels.Company details
What does DR. DESAIVE PATRICK do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. DESAIVE PATRICK?
DR. DESAIVE PATRICK is a private limited company (BV).
When was DR. DESAIVE PATRICK founded?
DR. DESAIVE PATRICK was founded on 18-12-2008.
Is DR. DESAIVE PATRICK still active?
Yes, DR. DESAIVE PATRICK is an active enterprise in the KBO register.
What is the turnover of DR. DESAIVE PATRICK?
The turnover in financial year 2025 is ≈ €98,000. This figure is estimated from the gross margin of €31,252 and 48 comparable companies (NACE 86). It probably lies between €70,000 and €140,000.Financials
Is DR. DESAIVE PATRICK profitable?
In financial year 2025, DR. DESAIVE PATRICK made a profit of €12,736.
Where can I find the annual accounts of DR. DESAIVE PATRICK?
DR. DESAIVE PATRICK filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. DESAIVE PATRICK due?
DR. DESAIVE PATRICK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.